Cargando…
Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy
BACKGROUND: Dose-limiting toxicities significantly impact the benefit/risk profile of many drugs. Whole genome sequencing (WGS) in patients receiving drugs with dose-limiting toxicities can identify therapeutic hypotheses to prevent these toxicities. Chemotherapy-induced peripheral neuropathy (CIPN)...
Autores principales: | Khan, Zia, Jung, Min, Crow, Megan, Mohindra, Rajat, Maiya, Vidya, Kaminker, Joshua S., Hackos, David H., Chandler, G. Scott, McCarthy, Mark I., Bhangale, Tushar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286344/ https://www.ncbi.nlm.nih.gov/pubmed/37344884 http://dx.doi.org/10.1186/s13073-023-01193-4 |
Ejemplares similares
-
Genetic variation associated with thyroid autoimmunity shapes the systemic immune response to PD-1 checkpoint blockade
por: Khan, Zia, et al.
Publicado: (2021) -
Baseline risk factors associated with immune related adverse events and atezolizumab
por: Madjar, Katrin, et al.
Publicado: (2023) -
GPR68: An Emerging Drug Target in Cancer
por: Wiley, Shu Z., et al.
Publicado: (2019) -
GPR68 Is a Neuroprotective Proton Receptor in Brain Ischemia
por: Wang, Tao, et al.
Publicado: (2020) -
OGR1 (GPR68) and TDAG8 (GPR65) Have Antagonistic Effects in Models of Colonic Inflammation
por: Perren, Leonie, et al.
Publicado: (2023)